Insider Stock Trading History of Cleveland Paul B


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Cleveland Paul B since year 2005. The trader's CIK number is 1376797. At the time of this reporting, Cleveland Paul B is the EVP, Corp. Development and CFO of Sangamo Biosciences Inc . (stock ticker symbol SGMO). See this page for all insider trading activities at Sangamo Biosciences Inc .

Note that in the past Cleveland Paul B also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Cleveland Paul B since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-01-15 SGMO Sangamo Biosciences Inc Sale 8,333 18.68 155,693
2014-01-15 SGMO Sangamo Biosciences Inc Option Ex 8,333 5.03 41,914
2013-12-02 SGMO Sangamo Biosciences Inc Option Ex 10,000 6.41 64,100
2013-12-02 SGMO Sangamo Biosciences Inc Sale 10,000 11.64 116,390
2013-10-21 SGMO Sangamo Biosciences Inc Option Ex 10,000 4.54 45,400
2013-10-21 SGMO Sangamo Biosciences Inc Sale 10,000 10.93 109,340
2013-09-03 SGMO Sangamo Biosciences Inc Option Ex 7,278 2.04 14,847
2013-09-03 SGMO Sangamo Biosciences Inc Sale 7,278 10.30 74,977
2013-07-15 SGMO Sangamo Biosciences Inc Option Ex 8,000 2.04 16,320
2013-07-15 SGMO Sangamo Biosciences Inc Sale 8,000 9.59 76,720
2011-02-28 SGMO Sangamo Biosciences Inc Sale 1,388 9.00 12,492
2011-02-28 SGMO Sangamo Biosciences Inc Option Ex 1,388 2.04 2,831
2010-12-22 SGMO Sangamo Biosciences Inc Option Ex 32,037 3.07 98,353
2010-12-22 SGMO Sangamo Biosciences Inc Sale 32,037 7.00 224,259
2010-12-20 SGMO Sangamo Biosciences Inc Option Ex 11,297 2.04 23,045
2010-12-20 SGMO Sangamo Biosciences Inc Sale 11,297 7.00 79,079
2010-02-25 AFFY Affymax Inc Option Ex 52,935 4.36 230,796
2010-02-25 AFFY Affymax Inc Sale 55,935 18.82 1,052,696

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cleveland Paul B (EVP, Corp. Development and CFO of Sangamo Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.